Advertisement
Screener

HYMAN CHARLES D Historic Quarter Change: Foreign Stocks, Added

HYMAN CHARLES D historic quarter change: Foreign Stocks, Added

In share positions in stocks (depositary receipts and foreign shares traded over the counter), over 15 quarters from 2013-06-30 to 2024-06-30, HYMAN CHARLES D opened 7 positions, added to 11, reduced 16 and sold out of 5.

  • Q2 2024: Stock TSM; Country of operation —; Class SPONSORED ADS; Shares before 3,089.
  • Q3 2016: Stock NWBO; Country of operation United States; Class COM PAR $0.001; Shares before 45,375.
  • Q2 2016: Stock DEO; Country of operation —; Class SPON ADR NEW; Shares before 15,425.
  • Q3 2015: Stock NWBO; Country of operation United States; Class COM; Shares before 33,375.

Each consecutive pair of Form 13F-HR filings compared (SEC CIK 1135077), 15 quarters: Q2 2024 (2024-03-31 to 2024-06-30, filed 2024-07-25); Q1 2024 (2023-12-31 to 2024-03-31, filed 2024-05-07); Q3 2016 (2016-06-30 to 2016-09-30, filed 2016-11-03); Q2 2016 (2016-03-31 to 2016-06-30, filed 2016-08-04); Q1 2016 (2015-12-31 to 2016-03-31, filed 2016-05-03); Q4 2015 (2015-09-30 to 2015-12-31, filed 2016-01-29); Q3 2015 (2015-06-30 to 2015-09-30, filed 2015-10-27); Q2 2015 (2015-03-31 to 2015-06-30, filed 2015-07-24); Q1 2015 (2014-12-31 to 2015-03-31, filed 2015-04-23); Q4 2014 (2014-09-30 to 2014-12-31, filed 2015-01-30); Q3 2014 (2014-06-30 to 2014-09-30, filed 2014-10-30); Q2 2014 (2014-03-31 to 2014-06-30, filed 2014-07-29); Q1 2014 (2013-12-31 to 2014-03-31, filed 2014-05-05); Q4 2013 (2013-09-30 to 2013-12-31, filed 2014-02-06); Q3 2013 (2013-06-30 to 2013-09-30, filed 2013-11-04). Rows for the same security, class and put/call are added together. Value change is the filed value at each quarter end, so it includes the price move. Only the filings held here are compared; the firm's 13F-HR filings go back to the quarter ended 2000-12-31. Not compared, as a quarter between them is not held here yet: 2016-09-30 to 2023-12-31 (missing 2016-12-31, 2017-03-31, 2017-06-30, 2017-09-30, 2017-12-31, 2018-03-31, 2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31, 2019-06-30, 2019-09-30, 2019-12-31, 2020-03-31, 2020-06-30, 2020-09-30, 2020-12-31, 2021-03-31, 2021-06-30, 2021-09-30, 2021-12-31, 2022-03-31, 2022-06-30, 2022-09-30, 2022-12-31, 2023-03-31, 2023-06-30, 2023-09-30).

QuarterStockCountry of operationClassShares beforeShares afterShare changeValue beforeValue afterValue changeFiled
Q2 2024TSM
TAIWAN SEMICONDUCTOR MFG LTD
SPONSORED ADS3,0893,314+225$420,000$576,000+$156,0002024-07-25
Q3 2016NWBO
NORTHWEST BIOTHERAPEUTICS IN
United StatesCOM PAR $0.00145,375249,625+204,250$26,000$135,000+$109,0002016-11-03
Q2 2016DEO
DIAGEO P L C
SPON ADR NEW15,42515,925+500$1,664,000$1,798,000+$134,0002016-08-04
Q3 2015NWBO
Northwest Biotherapeutics, Inc
United StatesCOM33,37545,375+12,000$331,000$284,000-$47,0002015-10-27
Q2 2015DEO
Diageo PLC New ADR
COM7,60015,550+7,950$840,000$1,804,000+$964,0002015-07-24
Q1 2015NWBO
Northwest Biotherapeutics, Inc
United StatesCOM41,37543,375+2,000$221,000$320,000+$99,0002015-04-23
Q2 2014DEO
Diageo PLC New ADR
COM10,10010,400+300$1,258,000$1,324,000+$66,0002014-07-29
Q2 2014NWBO
Northwest Biotherapeutics, Inc
United StatesCOM37,37541,375+4,000$271,000$278,000+$7,0002014-07-29
Q1 2014DEO
Diageo PLC New ADR
COM9,97510,100+125$1,321,000$1,258,000-$63,0002014-05-05
Q4 2013DEO
Diageo PLC New ADR
COM5,5509,975+4,425$705,000$1,321,000+$616,0002014-02-06
Q4 2013NWBO
Northwest Biotherapeutics, Inc
United StatesCOM20,37539,375+19,000$68,000$148,000+$80,0002014-02-06

Similar Firms

Firm NameCountry13F ValueHoldings
Not available yet